Micardis®. Observational Study in Patients With Essential Hypertension

MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

NCT02177396 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

NCT00240448 ·Status: COMPLETED ·Phase: PHASE4

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

NCT02242851 ·Status: COMPLETED

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

NCT00638911 ·Status: COMPLETED

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

NCT00034840 ·Status: COMPLETED ·Phase: PHASE4

Telmisartan in Mild to Moderate Hypertensive Patients

NCT02260089 ·Status: COMPLETED ·Phase: PHASE4

Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

NCT02248129 ·Status: COMPLETED

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

NCT00168779 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

NCT00219154 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

NCT05843162 ·Status: UNKNOWN ·Phase: PHASE4

Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study

NCT00909038 ·Status: COMPLETED

Telmisartan Tab Hypertension

NCT00890084 ·Status: COMPLETED

Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

NCT02521246 ·Status: WITHDRAWN ·Phase: PHASE3

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

NCT00471003 ·Status: COMPLETED

Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension

NCT00500604 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

NCT02261116 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

NCT00294710 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

NCT00400218 ·Status: COMPLETED ·Phase: PHASE3

Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

NCT04218552 ·Status: COMPLETED ·Phase: PHASE2

Antihypertensive Medications and the Risk of Sepsis

NCT02248896 ·Status: COMPLETED

Valsartan Intensified Primary Care Reduction of Blood Pressure Study

NCT00902304 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

NCT00219063 ·Status: COMPLETED ·Phase: PHASE3

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

NCT02016183 ·Status: COMPLETED

Antihypertensive Efficacy of Fixed Combination Drug

NCT01211314 ·Status: TERMINATED ·Phase: PHASE4

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

NCT00696436 ·Status: COMPLETED ·Phase: PHASE3